Prevalence and diversity of imported severe acute respiratory syndrome coronavirus 2 variants in China, 2021–2022

Yenan Feng,Xiang Zhao,Zhixiao Chen,Yuchao Wu,Lili Li,Changcheng Wu,Kai Nie,Xiaoyu Yang,Peihua Niu,Ji Wang,Shiwen Wang,Cao Chen
DOI: https://doi.org/10.1002/jmv.29664
IF: 20.693
2024-05-11
Journal of Medical Virology
Abstract:The causative agent of coronavirus disease 2019 (COVID‐19), known as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has spread accumulatively to 240 countries and continues to evolve. To gain a comprehensive understanding of the epidemiological characteristics of imported variants in China and their correlation with global circulating variants, genomic surveillance data from 11 139 imported COVID‐19 cases submitted by Chinese provincial CDC laboratories between 2021 and 2022 were analyzed. Consensus sequences underwent rigorous quality checks, followed by amino acid mutations analysis using Nextclade. Sequences with satisfactory quality control status were classified according to the Pango nomenclature. The results showed that the dominant variants in imported cases reflected the global epidemic trend. An increase in the number of imported SARS‐CoV‐2 lineages monitored in China in the second half of 2022, and the circulating Omicron subvariants changed from the ancestral lineages of BA.5 and BA.2 into the lineages containing key amino acid mutations of spike protein. There was significant variation in the detection of Omicron subvariants among continents (χ2 = 321.968, p
virology
What problem does this paper attempt to address?